Nuveen
PPH icon

Nuveen’s VanEck Pharmaceutical ETF PPH Stock Holding History

Nuveen’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.78K Buy
+16
New +$1.78K ﹤0.01% 4872

Other funds holding PPH

J. Safra Asset Management
J. Safra Asset Management New York $2.3B AUM 21.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Adamsbrown Wealth Consultants
Adamsbrown Wealth Consultants Wichita, Kansas $548M AUM 16.52% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
Rye Brook Capital
Rye Brook Capital Greenwich, Connecticut $154M AUM 17.54% 1-Year Est. Return
WT Wealth Management
WT Wealth Management Scottsdale, Arizona $357M AUM 15.82% 1-Year Est. Return
Prime Capital Investment Advisors
Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return
Fortis Group Advisors
Fortis Group Advisors Westwood, New Jersey $623M AUM 25.42% 1-Year Est. Return
Fluent Financial
Fluent Financial Dallas, Texas $292M AUM 8.92% 1-Year Est. Return

Nuveen's PPH Position: Q3 2026 in Review

Nuveen opened a new position in VanEck Pharmaceutical ETF (PPH) in Q3 2026: 16 shares worth $1.78K. The stake represents ﹤0.01% of the portfolio and ranks #4872 among its holdings.

84 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

  • Nuveen held 16 shares of VanEck Pharmaceutical ETF worth $1.78K as of Q3 2026.
  • VanEck Pharmaceutical ETF was a new Nuveen position in Q3 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4872 holding.
  • 84 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.